Clik here to view.
Shionogi Receives European Commission Marketing Authorisation for FETCROJA®...
OSAKA, Japan & AMSTERDAM FOR EUROPEAN MEDICAL AND PHARMA TRADE MEDIA ONLY Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President & CEO: Isao Teshirogi, Ph.D.) and its European...
View ArticleClik here to view.
Shionogi Accelerates Development of Potential COVID-19 Treatments and Vaccine
OSAKA, Japan & FLORHAM PARK, N.J. In response to the novel coronavirus (SARS-CoV-2), Shionogi & Co., Ltd. (hereafter “Shionogi”), a pharmaceutical company with a major focus on infectious...
View ArticleClik here to view.
BioDuro & neoX Partner to Create Next Generation Antibody Discovery Platform
SAN DIEGO & BEIJING BioDuro, LLC, a leading drug discovery and development services organization, and neoX, a leading-edge artificial intelligence and biophysics focused biotech, announced today...
View ArticleAVITA Medical Reports Third Quarter Fiscal 2020 Financial Results and Company...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in...
View ArticleClik here to view.
Neuraptive Therapeutics宣布FDA核准周围神经损伤患者治疗新药NTX-001的IND申请
费城 (美国商业资讯)–Neuraptive Therapeutics, Inc. (Neuraptive)是一家临床阶段生物技术公司，致力于开发新药和医疗产品以解决周围神经损伤(PNI)治疗中未获满足的需求。该公司今天宣布，美国食品药品管理局(FDA)已核准Neuraptive在研新药(IND) NTX-001用于急性单支横断性PNI患者的申请。 执行副总裁兼研发部主管Evan...
View ArticleClik here to view.
武田宣布mobocertinib (TAK-788)获美国FDA突破性治疗药物认证，用于治疗EGFR外显子20插入突变型NSCLC患者
马萨诸塞州剑桥和日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK)（“武田”）今天宣布，其在研药物mobocertinib...
View ArticleClik here to view.
武田薬品、米国FDAがEGFRエクソン20挿入変異を伴うNSCLC患者を治療するmobocertinib （TAK-788）を画期的治療薬に指定したと発表
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） —...
View ArticleClik here to view.
Puma Biotechnology and Bixink Therapeutics Enter into Exclusive Licensing...
LOS ANGELES Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, and Bixink Therapeutics, a new South Korean company working in the field of anti-cancer drugs and digital...
View ArticleSinovac Reports Unaudited Fourth Quarter 2019 Financial Results and Files...
BEIJING, China Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2019 annual report on Form 20-F with the U.S....
View ArticleClik here to view.
ニューラプティブ・セラピューティクス、末梢神経損傷患者を治療するための新規手法となるNTX-001のIND申請をFDAが承認と発表
フィラデルフィア （ビジネスワイヤ） — 末梢神経損傷（PNI）の治療における未充足ニーズに対処するための新規の治療薬と医療用製品の開発に専心する臨床段階のバイオテクノロジー企業であるニューラプティブ・セラピューティクス（以下、「ニューラプティブ」）は本日、急性単神経切断PNI患者でのNTX-001に対する当社の新薬臨床試験開始届（IND）を米国食品医薬品局（FDA）が承認したと発表しました。...
View ArticleClik here to view.
Study Finds Noninvasive, Continuous Masimo PVi® Monitoring More Valuable Than...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Anesthesiology and Reanimation Specialists’ Society in which researchers compared two...
View ArticleClik here to view.
Seoul Viosys Reports First Quarter 2020 Results
ANSAN, South Korea Seoul Viosys Co., Ltd. (“Seoul”) (KOSDAQ:092190), a leading global innovator of short wavelength LED products and technology, today announced KRW 87 billion for consolidated...
View ArticleClik here to view.
Utrecht University, Erasmus Medical Center and Harbour BioMed Researchers...
UTRECHT & ROTTERDAM, The Netherlands & CAMBRIDGE, Mass. & SUZHOU, China Researchers at Utrecht University, Erasmus Medical Center and Harbour BioMed (HBM) today reported that they have...
View ArticleClik here to view.
Teva and Celltrion Healthcare Announce the Launch of TRUXIMA®...
TEL AVIV, Israel & PARSIPPANY, N.J. & INCHEON, South Korea Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Celltrion...
View ArticleClik here to view.
手術中における輸液管理の指針として非侵襲的・連続的Masimo PVi®モニタリングが中心静脈圧測定よりも有益であることを示す研究
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、Journal of Anesthesiology and Reanimation Specialists’ Society誌に掲載された研究結果を発表しました。研究では、研究者らが、Masimo...
View ArticleClik here to view.
研究发现，无创连续Masimo PVi®监测对指导术中体液处治的价值优于中央静脉压测量
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布了《麻醉与复苏专家学会杂志》发表的一项研究结果，该研究的研究人员比较脊柱骨科手术中两种体液处治方法，包括Masimo PVi®。与有创间歇性中心静脉压(CVP)测量相比，无创连续脉搏灌注变异指数(PVi)监测时“心脏更稳定、补液更少、血管容积状况的评估结果更精准。”1 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Desmopressin Acetate...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the...
View ArticleClik here to view.
Noxopharm Achieves Abscopal Responses in Prostate Cancer
SYDNEY Noxopharm, a clinical-stage Australian oncology drug development company, has announced the details of the radiographic review of its DARRT-1 clinical study and is pleased to report a 27%...
View ArticleClik here to view.
Sinovac Announces First Animal Study Results of Vaccine Against COVID-19...
BEIJING Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today the publication of the preclinical study on...
View ArticleClik here to view.
Invicro LLC将建立医学影像数据集存储库以用于COVID-19研究
波士顿 (美国商业资讯)–柯尼卡美能达旗下公司Invicro LLC正与微软合作，创建免费的COVID-19诊断CT和X射线数据集存储库，以促进对这一全球威胁的认识和治疗。该存储库使用Invicro的iPACS®和微软Azure云平台中的先进技术，提供所需的安全性、私密性和运算能力。此项重要任务邀请并强烈鼓励全世界研究人员访问该数据并贡献COVID-19影像和临床数据。...
View Article